secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001809519-25-000015
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx appoints Scott Wagner as director, co-chair; Simon Patterson resigns from board
--------------------------------------------------------------------------------

- Scott Wagner appointed Class II director, Chair of Compensation Committee, and Co-Chair of the Board effective Jan 21, 2025.
- Wagner previously served as GoodRx Interim CEO from April 2023 to January 2025.
- Simon Patterson resigned as director, not due to any disagreement with Company or management.
- Vacancy filled by Silver Lake Stockholders exercising board designation rights; Wagner appointed.
- Wagner receives standard non-employee director compensation: initial RSU award of $420,000 and pro-rated annual RSU of $85,699.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/0001809519-25-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000015/gdrx-20250121.htm
  HTML page:      https://secwatch.observer/filing/0001809519-25-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer